Vern Norviel

Vern Norviel is a seasoned professional with extensive experience in law and advisory roles. Currently, Vern serves as a Partner at Wilson Sonsini Goodrich & Rosati since January 2002 and as the Founder and Board Member of Neuvivo since January 2020. Vern holds advisory and adjunct professorship responsibilities at Stanford University School of Medicine, focusing on the innovative MTRAM program as of October 2023. Additional roles include Strategic Advisor at the Ellison Institute of Technology Los Angeles, Special Adviser at Appletree Partners, Member of the Board of Trustees at the University of Colorado, TAP Board Member for The Leukemia & Lymphoma Society, and Chairman at the Morris Animal Foundation. Vern also lectures in the Global Entrepreneurship Course at the University of California, San Francisco, and serves on the Board of Overseers at Scripps Research, both roles commenced in 2019 and 2021, respectively.